Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sperm mitochondrial-associated cysteine-rich protein (SMCP) is a rapidly evolving cysteine- and proline-rich protein localized to the mitochondrial capsule of sperm. It has a characteristic tripartite structure (an N-terminal segment, a cysteine/proline/glutamine/lysine-rich central segment, and a C-terminal segment), and plays a crucial role in the structural integrity and stabilization of the helical mitochondrial sheath in the sperm flagellum. This stabilization is essential for sperm motility, and loss of SMCP function is linked to impaired sperm function and male infertility. The SMCP gene is found within the epidermal differentiation complex on human chromosome 1 and is expressed specifically in spermatogenic cells[1][2][3][4][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sperm mitochondrial-associated cysteine-rich protein (SMCP).